Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117230) titled 'Study on the regulatory mechanism of miR-21 in airway hyperresponsiveness of children with Mycoplasma pneumoniae pneumonia' on Jan. 21.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Shaoxing People's Hospital
Condition:
Mycoplasma pneumoniae pneumonia
Intervention:
children with MPP(experimental group):NA
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: children with MPP(experimental group):30;children with bronchial foreign bodies (control group):20;
Countries of Recruitment:
China
To know more, visit https:...